[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
[ Wed, Nov 23rd 2022 ]: WOPRAI
Erin Wright Initiated (UNH) at Buy and Held Target at $587 on, Nov 23rd, 2022
- 🞛 This publication is a summary or evaluation of another publication
Erin Wright of Morgan Stanley, Initiated "UnitedHealth Group Incorporated" (UNH) at Buy and Held Target at $587 on, Nov 23rd, 2022.
Erin has made no other calls on UNH in the last 4 months.
There are 9 other peers that have a rating on UNH. Out of the 9 peers that are also analyzing UNH, 2 agree with Erin's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Kevin Caliendo of "UBS" Maintained at Hold with Increased Target to $590 on, Wednesday, October 19th, 2022
- David Windley of "Jefferies" Maintained at Hold with Increased Target to $525 on, Monday, October 17th, 2022
These are the ratings of the 7 analyists that currently disagree with Erin
- John Ransom of "Raymond James" Downgraded from Strong Buy to Buy and Held Target at $615 on, Monday, November 21st, 2022
- George Hill of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $615 on, Tuesday, October 18th, 2022
- Whit Mayo of "SVB Leerink" Maintained at Buy with Decreased Target to $618 on, Monday, October 17th, 2022
- A.J. Rice of "Credit Suisse" Maintained at Buy with Increased Target to $590 on, Monday, October 17th, 2022
- Ben Hendrix of "RBC Capital" Maintained at Buy with Increased Target to $592 on, Monday, October 17th, 2022
- Ann Hynes of "Mizuho" Maintained at Strong Buy with Increased Target to $600 on, Wednesday, August 10th, 2022
- David Toung of "Argus Research" Maintained at Strong Buy with Increased Target to $650 on, Monday, July 25th, 2022